Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Facioscapulohumeral Muscular Dystrophy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Facet Joint Neurotomy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Facet Arthroplasty | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Facelift, Facial Thread Lift | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Eyelid Thermal Pulsation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Extracorporeal Shock Wave Therapy for Wounds | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Otoplasty and External Ear Reconstruction | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Powered Exoskeleton for Ambulation in Individuals with Lower-Limb Disabilities | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | MRI-Guided Focused Ultrasound (MRgFUS) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Evinacumab-dgnb (Evkeeza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Romosozumab-aqqg (Evenity) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Etranacogene Dezaparvovec-drlb (Hemgenix) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Eteplirsen (Exondys 51) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Eribulin Mesylate (Halaven) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Eptinezumab-jjmr (Vyepti) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Epoprostenol for Continuous Intravenous Infusion (Flolan/Veletri) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Epoetin Alfa Products(Epogen, Procrit, Retacrit) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Intraocular Radiation Therapy for Age-Related Macular Degeneration | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Epidural Steroid Injections for Treatment of Back Pain | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Epcoritamab-bysp (Epkinly) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Vedolizumab (Entyvio) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Enteral Nutrition/Home Hyperalimentation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Sutimlimab-jome (Enjaymo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Fam-trastuzumab Deruxtecan-nxki (Enhertu) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Enfortumab Vedotin-ejfv (Padcev) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Endothelial Keratoplasty | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Endometrial Ablation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Laparoscopic and Endoscopic Therapies for Gastroesophageal Reflux (GERD) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Minimally Invasive Endoscopic Procedures for Weight Loss | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Revakinagene Taroretcel-lwey (Encelto) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Telisotuzumab vedotin-tllv (Emrelis) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Emapalumab-lzsg (Gamifant) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Tagraxofusp-erzs (Elzonris) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Elranatamab-bcmm(Elrexfio) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Elotuzumab (Empliciti) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Elosulfase Alfa (Vimizim) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Elivaldogene Autotemcel (Skysona) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Pegunigalsidase Alfa-iwxj (Elfabrio) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Taliglucerase Alfa (Elelyso) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Hair Removal | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Transcutaneous Electrical Nerve Stimulation (TENS) and Transcutaneous Afferent Patterned Stimulation (TAPS) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Surface Electromyography (sEMG) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Spinal Cord Stimulation for the Treatment of Pain | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Percutaneous Electrical Nerve Stimulation (PENS), Percutaneous Neuromodulation Therapy (PNT) and Percutaneous Electrical Nerve Field Stimulation (PENFS) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Pelvic Floor Stimulation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Neuromuscular Electrical Stimulation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Navigated Transcranial Magnetic Stimulation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Interferential Current Stimulation | Criteria changed |